By Aaron Vehling ( September 23, 2014, 5:21 PM EDT) -- Canada takes a tough approach to so-called "pay-for-delay" deals between brand-name and generic drugmakers and is working on ways to ramp up enforcement of those agreements, Canada's competition chief said Tuesday during a speech at the George Mason University Pharma Conference....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.